Fourth Covid shot approved for over 65s
The Advisory Committee on Immunization Practices has approved a fourth dose of a coronavirus vaccine to people aged 65 and over and for residents of long-term care facilities.Individuals aged 18 and above who are immunocompromised have also been given the approval to receive a fifth vaccine dose.
That group has previously been approved to get an additional dose due to their weakened immune systems and a booster dose.They include cancer patients who have received treatment to suppress their immune system in the past year, organ or stem cell transplant recipients, people with moderate or severe primary immunodeficiency, dialysis patients and people with HIV.
The Central Epidemic Command Center says those receiving their fourth or fifth dose should get it at least five months after their last shot.
They can choose between the Moderna, Pfizer-BioNTech, Medigen, or Novavax brands.
Although Taiwan has yet to receive any doses of the Novavax vaccine, the government has ordered 2 million doses through the COVAX global vaccine sharing initiative.
Figures show that 84.24% of the population has received at least one dose, 79.49% has had two doses, and 55.99% has now received a third coronavirus vaccine dose.